About the Company
Chemo Iberica, S.A. develops and manufactures products for the life sciences sector. It focuses on the research and development of independent industrial synthetic methods for the production of active pharmaceutical ingredients (API), including PPI, steroids, macrolides, and sartans; and production of finished dosage forms, such as antiulcerants, antivirals, anitbiotics, contraceptives and HRT, and antifungals, as well as prod...
Chemo Iberica, S.A. develops and manufactures products for the life sciences sector. It focuses on the research and development of independent industrial synthetic methods for the production of active pharmaceutical ingredients (API), including PPI, steroids, macrolides, and sartans; and production of finished dosage forms, such as antiulcerants, antivirals, anitbiotics, contraceptives and HRT, and antifungals, as well as products for cholesterol, insomnia, asthma, and COPD. The company also manufactures and markets active substances that are used in the manufacture of veterinary drugs, such as antibiotics, anthelmintics, anti-inflammatory products, antiparasities, and coccidiostatic and chemotherapeutical drugs; and insecticides, fungicides, herbicides, and micronutrients for agrochemical formulations. In addition, it engages in various R&D activities that comprise development of solid formulation and analytical methods; up-scale and industrialization of production processes; validations of production processes and analytical methods; stability studies; clinical trials; and elaboration of dossiers for product registration. Chemo Iberica sells products to customers in Europe, Latin America, the United States, and Asia. Chemo Iberica, S.A. was founded in 1940 and is based in Barcelona, Spain. It has commercial offices in Spain, Switzerland, Hungary, China, India, Brazil, and Argentina; and industrial facilities in Spain, Italy, China, India, and Argentina.